Drug Interactions between Baraclude and Cotellic
This report displays the potential drug interactions for the following 2 drugs:
- Baraclude (entecavir)
- Cotellic (cobimetinib)
Interactions between your drugs
No interactions were found between Baraclude and Cotellic. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Baraclude
A total of 156 drugs are known to interact with Baraclude.
- Baraclude is in the drug class nucleoside reverse transcriptase inhibitors (NRTIs).
- Baraclude is used to treat Hepatitis B.
Cotellic
A total of 367 drugs are known to interact with Cotellic.
- Cotellic is in the drug class multikinase inhibitors.
- Cotellic is used to treat the following conditions:
Drug and food interactions
entecavir food
Applies to: Baraclude (entecavir)
You may experience reduced absorption of entecavir in the presence of food. Take entecavir on an empty stomach 2 hours before or 2 hours after a meal unless otherwise directed by your doctor. This will make it easier for your body to absorb the medication. It is important to take entecavir regularly to get the most benefit.
cobimetinib food
Applies to: Cotellic (cobimetinib)
Grapefruit juice may increase the blood levels and effects of certain medications such as cobimetinib. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with cobimetinib. However, if you have been regularly consuming grapefruit or grapefruit juice with cobimetinib, do not alter the amounts of these products in your diet without first talking to your doctor or other healthcare professional. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.